DDInter948 DDInter306
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
Caspofungin (brand name Cancidas worldwide) is an antifungal drug and the first member of a new drug class called the echinocandins, as coined by Merck & Co., Inc. It is typically administered intravenously. It shows activity against infections with Aspergillus and Candida, and works by inhibiting β(1,3)-D-Glucan of the fungal cell wall.
Caspofungin {u} (Compound) resembles {v} (Compound) Anidulafungin
Caspofungin {u} (Compound) resembles {v} (Compound) Polymyxin B
Caspofungin {u} (Compound) binds {v} (Gene) CYP3A4
Caspofungin {u} (Compound) is included by {v} (Pharmacologic Class) Lipopeptides
Caspofungin {u} (Compound) causes {v} (Side Effect) Oedema peripheral
Caspofungin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Naltrexone
Caspofungin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Interferon beta-1a
Caspofungin {u} may lead to a major life threatening interaction when taken with {v} Dexamethasone
Caspofungin (Compound) resembles Anidulafungin (Compound)
Caspofungin (Compound) resembles Polymyxin B (Compound)
Caspofungin (Compound) binds CYP3A4 (Gene)
Caspofungin (Compound) is included by Lipopeptides (Pharmacologic Class)
Caspofungin (Compound) causes Oedema peripheral (Side Effect)
Caspofungin may cause a moderate interaction that could exacerbate diseases when taken with Naltrexone
Caspofungin may cause a moderate interaction that could exacerbate diseases when taken with Interferon beta-1a
Caspofungin may lead to a major life threatening interaction when taken with Dexamethasone